204 related articles for article (PubMed ID: 24928137)
1. Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect.
Jøraholmen MW; Vanić Z; Tho I; Skalko-Basnet N
Int J Pharm; 2014 Sep; 472(1-2):94-101. PubMed ID: 24928137
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
Ning M; Gu Z; Pan H; Yu H; Xiao K
Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
[TBL] [Abstract][Full Text] [Related]
3. Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine.
Szymańska E; Winnicka K; Amelian A; Cwalina U
Chem Pharm Bull (Tokyo); 2014; 62(2):160-7. PubMed ID: 24492586
[TBL] [Abstract][Full Text] [Related]
4. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy.
Andersen T; Bleher S; Eide Flaten G; Tho I; Mattsson S; Škalko-Basnet N
Mar Drugs; 2015 Jan; 13(1):222-36. PubMed ID: 25574737
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.
Andersen T; Mishchenko E; Flaten GE; Sollid JU; Mattsson S; Tho I; Škalko-Basnet N
Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28273850
[TBL] [Abstract][Full Text] [Related]
6. Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin.
Berginc K; Suljaković S; Škalko-Basnet N; Kristl A
Eur J Pharm Biopharm; 2014 May; 87(1):40-6. PubMed ID: 24534774
[TBL] [Abstract][Full Text] [Related]
7. Optimization, characterization and evaluation of chitosan-tailored cubic nanoparticles of clotrimazole.
Verma P; Ahuja M
Int J Biol Macromol; 2015 Feb; 73():138-45. PubMed ID: 25463320
[TBL] [Abstract][Full Text] [Related]
8. The Antimicrobial Properties of Chitosan Can be Tailored by Formulation.
Jøraholmen MW; Bhargava A; Julin K; Johannessen M; Škalko-Basnet N
Mar Drugs; 2020 Jan; 18(2):. PubMed ID: 32023890
[TBL] [Abstract][Full Text] [Related]
9. Effect of chitosan coating on microemulsion for effective dermal clotrimazole delivery.
Kumari B; Kesavan K
Pharm Dev Technol; 2017 Jun; 22(4):617-626. PubMed ID: 27574791
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
[TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Karimunnisa S; Atmaram P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Characterization of Sertaconazole Nitrate Mucoadhesive Liposomes for Vaginal Candidiasis.
Abdellatif MM; Khalil IA; Elakkad YE; Eliwa HA; Samir TM; Al-Mokaddem AK
Int J Nanomedicine; 2020; 15():4079-4090. PubMed ID: 32606665
[TBL] [Abstract][Full Text] [Related]
13. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.
Refai H; Hassan D; Abdelmonem R
Drug Deliv; 2017 Nov; 24(1):278-288. PubMed ID: 28165805
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
[TBL] [Abstract][Full Text] [Related]
16. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems.
Takeuchi H; Thongborisute J; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
Adv Drug Deliv Rev; 2005 Nov; 57(11):1583-94. PubMed ID: 16169120
[TBL] [Abstract][Full Text] [Related]
17. Controlled-release biodegradable nanoparticles: From preparation to vaginal applications.
Martínez-Pérez B; Quintanar-Guerrero D; Tapia-Tapia M; Cisneros-Tamayo R; Zambrano-Zaragoza ML; Alcalá-Alcalá S; Mendoza-Muñoz N; Piñón-Segundo E
Eur J Pharm Sci; 2018 Mar; 115():185-195. PubMed ID: 29208486
[TBL] [Abstract][Full Text] [Related]
18. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Abdelbary G
Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
[TBL] [Abstract][Full Text] [Related]
19. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of chitosan microgranules with clotrimazole.
Szymańska E; Winnicka K
Acta Pol Pharm; 2012; 69(3):509-13. PubMed ID: 22594265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
